HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Pulmonary Heart Diseases
Pulmonary Heart Diseases
Pulmonary heart diseases occur when the heart's right ventricle struggles to pump blood due to increased pressure in the pulmonary arteries, commonly caused by conditions like pulmonary hypertension and chronic lung diseases. This strain can lead to the enlargement of the right side of the heart, making it less efficient in its function. While pulmonary heart diseases are a serious concern, early diagnosis and treatment can help manage symptoms and improve the quality of life. Treatments typically focus on controlling the underlying lung disease, using medications to relieve pressure in the lungs, and, in more severe cases, providing oxygen therapy or considering surgical interventions.
Committee Members
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States Cardio 2026 Speakers
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico